CMS plans to test changes in the way Medicare Part B pays providers to administer treatments, according to an agency transmittal to Medicare contractors , and lobbyists expect the president's budget request to highlight the demonstrations as an effort to deal with rising drug prices. CMS expects to begin the demos this summer. The current Medicare method for paying physicians to administer drugs, typically biologics, has been criticized as encouraging providers to use expensive products because a portion of provider...